Bone Morphogenetic Protein (BMP)-4 and BMP-7 regulate differentially Transforming Growth Factor (TGF)-β1 in normal human lung fibroblasts (NHLF)

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Pegorier, Sophie ^a   Campbell, Gaynor A ^a   Kay, A Barry ^a   Lloyd, Clare M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BONE MORPHOGENETIC PROTEIN 4; COLLAGEN TYPE 1; COLLAGEN TYPE 4; FIBRONECTIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; OSTEOGENIC PROTEIN 1; SCLEROPROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1; TRITIUM; ACTIN; BMP4 PROTEIN, HUMAN; BMP7 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN RECEPTOR; COLLAGENASE 3; GELATINASE A; MMP13 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

AIRWAY REMODELING; ARTICLE; ASTHMA; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG FIBROBLAST; LUNG FIBROSIS; MYOFIBROBLAST; NORMAL HUMAN LUNG FIBROBLAST; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY; CELL CULTURE; CELL SURVIVAL; FIBROBLAST; FIBROSIS; GENETICS; LUNG; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; AIRWAY REMODELING; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEIN RECEPTORS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE IV; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; FIBRONECTINS; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 77956677107     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-85     Document Type: Article

References (53)

1. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000, 161(5):1720-1745.
2. James AL, Wenzel S. Clinical relevance of airway remodelling in airway diseases. Eur Respir J 2007, 30(1):134-155. 10.1183/09031936.00146905, 17601971.
3. Lloyd CM, Robinson DS. Allergen-induced airway remodelling. Eur Respir J 2007, 29(5):1020-1032. 10.1183/09031936.00150305, 17470623.
4. Munz B, Hubner G, Tretter Y, Alzheimer C, Werner S. A novel role of activin in inflammation and repair. J Endocrinol 1999, 161(2):187-193. 10.1677/joe.0.1610187, 10320815.
5. Makinde T, Murphy RF, Agrawal DK. The regulatory role of TGF-beta in airway remodeling in asthma. Immunol Cell Biol 2007, 85(5):348-356. 10.1038/sj.icb.7100044, 17325694.
6. Chen D, Zhao M, Harris SE, Mi Z. Signal transduction and biological functions of bone morphogenetic proteins. Front Biosci 2004, 9:349-358. 10.2741/1090, 14766372.
7. Szefler SJ. Airway remodeling: therapeutic target or not?. Am J Respir Crit Care Med 2005, 171(7):672-673. 10.1164/rccm.2501001, 15790863.
8. McMillan SJ, Xanthou G, Lloyd CM. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol 2005, 174(9):5774-5780.
9. Khalil N, Xu YD, O'Connor R, Duronio V. Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK. J Biol Chem 2005, 280(52):43000-43009. 10.1074/jbc.M510441200, 16246848.
10. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene 2004, 23(9):1656-1667. 10.1038/sj.onc.1207064, 15001984.
11. Evans RA, Tian YC, Steadman R, Phillips AO. TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. Exp Cell Res 2003, 282(2):90-100. 10.1016/S0014-4827(02)00015-0, 12531695.
12. Phipps S, Benyahia F, Ou TT, Barkans J, Robinson DS, Kay AB. Acute allergen-induced airway remodeling in atopic asthma. Am J Respir Cell Mol Biol 2004, 31(6):626-632. 10.1165/rcmb.2004-0193OC, 15333330.
13. Camara J, Jarai G. Epithelial-mesenchymal transition in primary human bronchial epithelial cells is SMad-dependent and enhanced by fibronectin and TNF-alpha. Fibrogenesis & Tissue Repair 2010, 3(2).
14. Schmidt-Weber CB, Blaser K. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. Curr Opin Immunol 2004, 16(6):709-716. 10.1016/j.coi.2004.09.008, 15511662.
15. Chen G, Khalil N. TGF-beta1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases. Respir Res 2006, 7:2. 10.1186/1465-9921-7-2, 1360679, 16390551.
16. Alcorn JF, Rinaldi LM, Jaffe EF, van Loon M, Bates JH, Janssen-Heininger YM, Irvin CG. Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease. Am J Respir Crit Care Med 2007, 176(10):974-982. 10.1164/rccm.200702-334OC, 2078678, 17761617.
17. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004, 22(4):233-241. 10.1080/08977190412331279890, 15621726.
18. Reddi AH. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev 1997, 8(1):11-20. 10.1016/S1359-6101(96)00049-4, 9174660.
19. Gonzalez EA, Lund RJ, Martin KJ, McCartney JE, Tondravi MM, Sampath TK, Hruska KA. Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7. Kidney Int 2002, 61(4):1322-1331. 10.1046/j.1523-1755.2002.00258.x, 11918739.
20. Izumi N, Mizuguchi S, Inagaki Y, Saika S, Kawada N, Nakajima Y, Inoue K, Suehiro S, Friedman SL, Ikeda K. BMP-7 opposes TGF-beta1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2. Am J Physiol Lung Cell Mol Physiol 2006, 290(1):L120-126. 10.1152/ajplung.00171.2005, 16126788.
21. Klahr S. The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function. J Nephrol 2003, 16(2):179-185.
22. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int Suppl 2003, (87):S105-112. 10.1046/j.1523-1755.64.s87.16.x, 14531782.
23. Maric I, Poljak L, Zoricic S, Bobinac D, Bosukonda D, Sampath KT, Vukicevic S. Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. J Cell Physiol 2003, 196(2):258-264. 10.1002/jcp.10275, 12811818.
24. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003, 9(7):964-968. 10.1038/nm888, 12808448.
25. Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, Muller GA, Kalluri R. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 2003, 285(6):F1060-1067.
26. Zeisberg M, Shah AA, Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 2005, 280(9):8094-8100. 10.1074/jbc.M413102200, 15591043.
27. Murray LA, Hackett TL, Warner SM, Shaheen F, Argentieri RL, Dudas P, Farrell FX, Knight DA. BMP-7 does not protect against bleomycin-induced lung or skin fibrosis. PLoS ONE 2008, 3(12):e4039. 10.1371/journal.pone.0004039, 2603595, 19112509.
28. Dudas PL, Argentieri RL, Farrell FX. BMP-7 fails to attenuate TGF-{beta}1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells. Nephrol Dial Transplant 2008,
29. Shannon JM, Hyatt BA. Epithelial-mesenchymal interactions in the developing lung. Annu Rev Physiol 2004, 66:625-645. 10.1146/annurev.physiol.66.032102.135749, 14977416.
30. Jeffery TK, Upton PD, Trembath RC, Morrell NW. BMP4 inhibits proliferation and promotes myocyte differentiation of lung fibroblasts via Smad1 and JNK pathways. Am J Physiol Lung Cell Mol Physiol 2005, 288(2):L370-378. 10.1152/ajplung.00242.2004, 15516492.
31. Kariyawasam HH, Xanthou G, Barkans J, Aizen M, Kay AB, Robinson DS. Basal Expression of Bone Morphogenetic Protein (BMP) Receptor is Reduced in Mild Asthma. Am J Respir Crit Care Med 2008, 177(10):1074-81. 10.1164/rccm.200709-1376OC, 18292470.
32. Gould SE, Day M, Jones SS, Dorai H. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 2002, 61(1):51-60. 10.1046/j.1523-1755.2002.00103.x, 11786084.
33. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3(7):RESEARCH0034. 10.1186/gb-2002-3-7-research0034, 126239, 12184808.
34. Tesseur I, Zou K, Berber E, Zhang H, Wyss-Coray T. Highly sensitive and specific bioassay for measuring bioactive TGF-beta. BMC Cell Biol 2006, 7:15. 10.1186/1471-2121-7-15, 1479809, 16549026.
35. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993, 122(1):103-111. 10.1083/jcb.122.1.103, 2119614, 8314838.
36. Yamauchi K, Inoue H. Airway remodeling in asthma and irreversible airflow limitation-ECM deposition in airway and possible therapy for remodeling. Allergol Int 2007, 56(4):321-329. 10.2332/allergolint.R-07-151, 17965575.
37. Gueders MM, Foidart JM, Noel A, Cataldo DD. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 2006, 533(1-3):133-144. 10.1016/j.ejphar.2005.12.082, 16487964.
38. Chambers RC, Leoni P, Kaminski N, Laurent GJ, Heller RA. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol 2003, 162(2):533-546. 1851161, 12547711.
39. Kurosaka H, Kurosaka D, Kato K, Mashima Y, Tanaka Y. Transforming growth factor-beta 1 promotes contraction of collagen gel by bovine corneal fibroblasts through differentiation of myofibroblasts. Invest Ophthalmol Vis Sci 1998, 39(5):699-704.
40. Grotendorst GR. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 1997, 8(3):171-179. 10.1016/S1359-6101(97)00010-5, 9462483.
41. Burgess JK. Connective tissue growth factor: a role in airway remodelling in asthma?. Clin Exp Pharmacol Physiol 2005, 32(11):988-994. 10.1111/j.1440-1681.2005.04296.x, 16405457.
42. Pelaia G, Gallelli L, D'Agostino B, Vatrella A, Cuda G, Fratto D, Renda T, Galderisi U, Piegari E, Crimi N, Rossi F, Caputi M, Costanzo FS, Vancheri C, Maselli R, Marsico SA. Effects of TGF-beta and glucocorticoids on map kinase phosphorylation, IL-6/IL-11 secretion and cell proliferation in primary cultures of human lung fibroblasts. J Cell Physiol 2007, 210(2):489-497. 10.1002/jcp.20884, 17044077.
43. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004, 303(5659):848-851. 10.1126/science.1090922, 14764882.
44. Duvernelle C, Freund V, Frossard N. Transforming growth factor-beta and its role in asthma. Pulm Pharmacol Ther 2003, 16(4):181-196. 10.1016/S1094-5539(03)00051-8, 12850120.
45. Phan SH. The myofibroblast in pulmonary fibrosis. Chest 2002, 122(6 Suppl):286S-289S. 10.1378/chest.122.6_suppl.286S, 12475801.
46. Im HJ, Pacione C, Chubinskaya S, Van Wijnen AJ, Sun Y, Loeser RF. Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes. J Biol Chem 2003, 278(28):25386-25394. 10.1074/jbc.M302048200, 2895259, 12734180.
47. Li H, Simon H, Bocan TM, Peterson JT. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition. Cardiovasc Res 2000, 46(2):298-306. 10.1016/S0008-6363(00)00028-6, 10773234.
48. Otto TC, Bowers RR, Lane MD. BMP-4 treatment of C3H10T1/2 stem cells blocks expression of MMP-3 and MMP-13. Biochem Biophys Res Commun 2007, 353(4):1097-1104. 10.1016/j.bbrc.2006.12.170, 17204246.
49. ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin CH, Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 1994, 269(25):16985-16988.
50. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, Miyazono K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 1995, 92(17):7632-7636. 10.1073/pnas.92.17.7632, 41199, 7644468.
51. Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J Biol Chem 1998, 273(40):25628-25636. 10.1074/jbc.273.40.25628, 9748228.
52. Le AV, Cho JY, Miller M, McElwain S, Golgotiu K, Broide DH. Inhibition of allergen-induced airway remodeling in Smad 3-deficient mice. J Immunol 2007, 178(11):7310-7316.
53. Koli K, Myllarniemi M, Vuorinen K, Salmenkivi K, Ryynanen MJ, Kinnula VL, Keski-Oja J. Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis. Am J Pathol 2006, 169(1):61-71. 10.2353/ajpath.2006.051263, 1698771, 16816361.